Atlas Trials

Demonstrate the Effects of Pramlintide on Weight Reduction in Schizophrenia

Clinical trial NCT00690235 · COMPLETED

Trial details

NCT number
NCT00690235
Sponsor
University of Texas Southwestern Medical Center
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
SchizophreniaSchizoaffective DisorderDiabetesWeight Gain
Start date
2007-11-01
Primary completion
2011-08-01
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.